What Has Been The Evolution of the Veterinary Renal Disease Market in Recent Years?
The veterinary renal disease market has seen considerable growth due to a variety of factors.
• The veterinary renal disease market has seen strong growth in recent years. It will grow from $15.5 billion in 2024 to $16.63 billion in 2025, at a CAGR of 7.3%.
This growth is linked to greater awareness initiatives, a shift toward natural and organic pet food, the increasing rate of pet ownership worldwide, regulatory changes in veterinary pharmaceuticals, and growing knowledge of pet health and nutrition.
What Are the Future Growth Projections for the Veterinary Renal Disease Market?
The veterinary renal disease market is expected to maintain its strong growth trajectory in upcoming years.
• The veterinary renal disease market is projected to grow to $21.74 billion by 2029 at a CAGR of 6.9%.
This growth is driven by personalized veterinary medicine, expansion of veterinary telemedicine and remote monitoring, more veterinary clinical trials and research, blockchain technology adoption for supply chain transparency, and the integration of AI and machine learning in diagnostics. Trends include increased demand for veterinary teleconsultations, custom pet nutrition plans, wearable health devices for pets, the growth of telemedicine platforms, and the adoption of precision medicine in veterinary oncology.
What Are The Core Factors Supporting Growth In The Veterinary Renal Disease Market?
The veterinary renal disease market is predicted to experience significant growth owing to the increasing number of pets. Veterinary renal disease refers to conditions impacting kidney function in animals, which could result in symptoms such as excess thirst, frequent urination, decreased appetite, and weight loss. Factors such as extended pet lifespan, exposure to environmental toxins, dietary elements, and inherited tendencies contribute to the rise of veterinary renal disease. To manage these conditions in pets, treatments usually include dietary regulation, medication, and fluid therapy to help ease symptoms, hinder disease advancement, and enhance pets' life quality. As per data from Cooper Pet Care, a mobile pet care platform in the Netherlands, by October 2022, the European Union, encompassing Norway and Switzerland, will house nearly 145 million pet animals, marking an increase of 5 million pets from the prior year, which was approximately 140 million. This number includes around 66 million dogs and 79 million cats. Consequently, the upsurge in pet ownership plays a key role in escalating the growth of the veterinary renal disease market.
What Are The Major Segments Within The Global Veterinary Renal Disease Market?
The veterinary renal disease market covered in this report is segmented –
1) By Type: Diagnosis, Treatment
2) By Animal Type: Canine, Feline, Bovine, Equine, Other Animal Types
3) By Indication: Renal Failure, Chronic Kidney Disease (CKD), Renal Cystitis, Kidney Stones, Nephritis, Other Indications
4) By Route of Administration: Injectable, Oral
5) By Distribution Channel: Pharmacies, Pet Specialty Stores, E-commerce, Other Distribution Channels
Subsegments:
1) By Diagnosis: Blood Tests, Urine Tests, Imaging, Biopsy
2) By Treatment: Medications, Dialysis, Kidney Transplantation, Fluid Therapy
Pre-Book The Veterinary Renal Disease Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Veterinary Renal Disease Market?
Key players in the veterinary renal malady market are concentrating on introducing technological progressions in the fields of treatment and diagnosis. They are pioneering new diagnostic procedures with the potential to pinpoint kidney damage even when there are no clear clinical symptoms presented. These diagnostic tests target the detection of kidney damage with a focus on identifying minute changes in renal function or structures. This can help in applying early interventions to halt the development into severe stages of renal dysfunction. A notable example is the launch of the first diagnostic test for detecting kidney damage in cats and dogs by IDEXX Laboratories Inc., in June 2023. The US-based company, which develops and manufactures veterinary products and services, introduced the IDEXX Cystatin B Test. This test was created with the purpose of allowing veterinarians to identify kidney damage prior to the detection of alterations in kidney functionality. This proactive detection could eventually lead to improved patient results. The IDEXX Cystatin B Test is set to be incorporated into panels assessing renal health. It is expected to provide significant information during around two million patient consultations every year.
Who Are the Key Players In The Veterinary Renal Disease Market?
Major companies operating in the veterinary renal disease market are:
• Bayer HealthCare Animal Health Inc.
• Nestlé Purina PetCare Company
• Zoetis Inc.
• Boehringer Ingelheim
• Covetrus Inc.
• Elanco Animal Health Incorporated
• Hill's Pet Nutrition Inc.
• IDEXX Laboratories Inc.
• Ceva Santé Animale S.A.
• Dechra Pharmaceuticals PLC
• Neogen Corporation
• Vetoquinol S.A.
• Norbrook Laboratories Limited
• Nutramax Laboratories Veterinary Sciences Inc.
• Animalcare Group plc
• Antech Diagnostics Inc.
• Kindred Biosciences Inc.
• Vedco Inc.
• MSD Animal Health
• Clinical Renal Associates
• Veterinary Transplant Services Inc.
• Kibow Biotech Inc.
• Northwest Renal Clinic
What Is The Most Dominant Region In The Veterinary Renal Disease Market?
North America was the largest region in the veterinary renal disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary renal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
